The Latest Cardiac and Vascular News
Study demonstrated safety and tolerability of Tyvaso DPI™ in patients with PAH transitioning from Tyvaso® Inhalation Solution A separate study in healthy volunteers demonstrated comparable treprostinil exposure between Tyvaso DPI and Tyvaso Inhalation Solution Tyvaso DPI NDA filing anticipated in April 2021 with priority review SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, […]
Innovative Technologies Improve the Treatment of Persistent AF Patients CARLSBAD, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB) today announced the presentation of two mapping and ablation procedures during the 26th Annual International AF Symposium demonstrating the beneficial capabilities of guided ablation therapy utilizing the company’s entire diagnostic […]
SAN CARLOS, Calif., Jan. 21, 2021 /PRNewswire/ — Galaxy Medical, a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the proprietary CENTAURI™ System will be featured in a recorded case presentation on Sunday January 31st during the upcoming AF Symposium. Ante Anić, EP Lab Director at University Hospital […]
VALHALLA, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) — Retia Medical, a leading provider of minimally-invasive hemodynamic monitoring technology today announced it received CE (Conformitè Europëenne) Mark approval for its Argos Cardiac Output Monitor. Retia’s CEO Marc Zemel stated, “Obtaining the CE mark for the Argos Cardiac Output Monitor is a […]
National Institutes of Health grant will support Cardialen’s development of its implantable, low-energy therapy designed to treat atrial fibrillation, a cardiac arrhythmia associated with debilitating shortness of breath, fatigue, pain, and an increased risk of stroke. MINNEAPOLIS–(BUSINESS WIRE)–Cardialen, Inc., has been awarded a $2.8 million National Institutes of Health (NIH) […]
TORONTO, Jan. 19, 2021 /PRNewswire/ — Baylis Medical announced today the launch and first clinical case in Europe of the JLL 2-French electrophysiology microcatheter, performed by Dr. Thomas Deneke at Heart Center, Bad Neustadt, Germany. The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, by making available the smallest diagnostic catheter in the […]
Ongoing Trial to Evaluate Optimal Dose Selected from Dose-Ranging Stage of the INSTANT Study for Rapid Conversion of Atrial Fibrillation to Normal Sinus Rhythm SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) — InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today announced dosing […]
Canadian company drives at-home cardiac monitoring nationwide during pandemic QUEBEC CITY, Jan. 19, 2021 (GLOBE NEWSWIRE) — Icentia Inc., a leading Canadian technology company—specialised in cardiac ambulatory monitoring—will be providing a new home-based service nationwide that will enable patients with heart rhythm disorders to have access to an ambulatory cardiac […]
Westport, CT, Jan. 14, 2021 (GLOBE NEWSWIRE) — Leading industry publication calls attention to ongoing challenges in the electrophysiology lab PURE EP System is highlighted as a novel technological solution BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed […]
Wearable ECG monitor used in study on Emotion Dysregulation and Sleep Time Masticatory Muscle Activity CAMPBELL, Calif., Jan. 13, 2021 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions, announces an agreement to supply its wearable ECG monitors to Stanford University for research on sleep bruxism. Titled “Emotion Dysregulation and Sleep-Time Masticatory Muscle Activity […]
